Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Redefining Diabetes Care: IACS Injections and Blood Sugar Management
Copy link
Facebook
Email
Notes
More

Redefining Diabetes Care: IACS Injections and Blood Sugar Management

Insights from a Mayo Clinic Study on IACS Injections and Diabetes Risk

Naveen Sankar S's avatar
Naveen Sankar S
Jan 25, 2024
∙ Paid

Share this post

Just Healthcare
Just Healthcare
Redefining Diabetes Care: IACS Injections and Blood Sugar Management
Copy link
Facebook
Email
Notes
More
Share

Topline:

A groundbreaking study by the Mayo Clinic reveals that intra-articular corticosteroid (IACS) injections, while temporarily raising blood sugar levels, generally do not exacerbate diabetes progression. This finding is crucial for both patients and healthcare providers to manage the delicate balance between arthritis treatment and glycemic control.

Study Details:

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More